COST-Aktionen offen für österreichische Beteiligungen im Bereich "Medical and Health Sciences"

Durch Anklicken der Nummer gelangen Sie zur entsprechenden COST-Aktion auf www.cost.eu

Sie möchten sich als Mitglied des Management Committees bewerben? Dann schicken Sie uns Ihre Bewerbung über den FFG eCall!

Nummer Titel
CA23156 CA23156 European Network for Sigma-1 Receptor as a Therapeutic Opportunity 
CA23153 Digital Mental Health for Young People 
CA23152 Building Consensus on Biofilm Regulatory Decision Making 
CA23151 Mediterranean Cancer Screening and Early Diagnosis Network 
CA23142 Developing Knowledge involved in diagnosis and control of human-diseases related to Pneumocystis 
CA23140 Boost and secure ATMP for BURN patient 
CA23133 Large-scale Interdisciplinary Alliance on Nature-based SoLutions and Health: Indicators, InequalitY and Innovation
CA23125 The mETamaterial foRmalism approach to recognize cAncer 
CA23119 SENESCENCE2030: Targeting Cell Senescence to Prevent Age-Related Diseases 
CA23113 Climate change impacts on mental health in Europe 
CA23110 International networking on in vitro colon models simulating gut microbiota mediated interactions
CA23106 An Evolutionary View to Understanding Affective States across Species
CA22139 Justice to youth language needs: human rights undermined by an invisible disadvantage
CA22125 Precision medicine in biliary tract cancer
CA22119 Haemoglobinopathies in European Liaison of Medicine and Science
CA22118 Radionuclide theragnostics for personalised medicine
CA22114 Maternal Perinatal Stress and Adverse Outcomes in the Offspring: Maximising infants´development
CA22106 Migrant Disaster Victim Identification
CA21168 Improving outcome of Juvenile Inflammatory Rheumatism via universally applicable clinical practice
CA21165 Personalized medicine in chronic kidney disease: improved outcome based on Big Data
CA21164 TowArDs an improVement in diAgNostiCs and trEatment strategies for TB control
CA21152 Implementation Network Europe for Cancer Survivorship Care
CA21147 European Network on Optimising Treatment with Therapeutic Antibodies in chronic inflammatory diseases
CA21145 European Network for diagnosis and treatment of antibiotic-resistant bacterial infections
CA21140 INTercEption of oRal CancEr develoPmenT
CA21137 Ethics in Dementia
CA21130 P2X receptors as a therapeutic opportunity
CA21123 Cancer- Understanding Prevention in Intellectual Disabilities
CA21117 The role of IMMUnity in tackling PARKinson’s disease through a Translational NETwork
CA21116 Identification of biological markers for prevention and translational medicine in pancreatic cancer
CA21113 Genome Editing to Treat Humans Diseases
CA21111 One Health drugs against parasitic vector borne diseases in Europe and beyond
CA20135 Improving biomedical research by automated behaviour monitoring in the animal home-cage
CA20124 Maximising impact of multidisciplinary research in early diagnosis of neonatal brain injury
CA20122 Harmonizing clinical care and research on adrenal tumours in European countries
CA20119 European andrology network – research coordination, education and public awareness
CA20114 Therapeutical applications of Cold Plasmas